Seroatlas · Human Serome Atlas

NAT8L

N-acetylaspartate synthetase

Also known as: FLJ37478, Hcml3, NAT8L_HUMAN, Shati

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q8N9F0
Gene
NAT8L
Ensembl
ENSG00000185818
Chromosome
4
Canonical length
302 aa
Protein class
Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins
Subcellular location
Mitochondria

OverviewNCBI Gene

This gene encodes a single-pass membrane protein, which contains a conserved sequence of the GCN5 or NAT superfamily of N-acetyltransferases and is a member of the N-acyltransferase (NAT) superfamily. This protein is a neuron-specific protein and is the N-acetylaspartate (NAA) biosynthetic enzyme, catalyzing the NAA synthesis from L-aspartate and acetyl-CoA. NAA is a major storage and transport form of acetyl coenzyme A specific to the nervous system. The gene mutation results in primary NAA deficiency (hypoacetylaspartia). [provided by RefSeq, Dec 2010]

Canonical amino-acid sequenceUniProt

302 residues, UniProt reviewed canonical sequence.

>Q8N9F0|NAT8L
     1  MHCGPPDMVC ETKIVAAEDH EALPGAKKDA LLAAAGAMWP PLPAAPGPAA APPAPPPAPV
    61  AQPHGGAGGA GPPGGRGVCI REFRAAEQEA ARRIFYDGIM ERIPNTAFRG LRQHPRAQLL
   121  YALLAALCFA VSRSLLLTCL VPAALLGLRY YYSRKVIRAY LECALHTDMA DIEQYYMKPP
   181  GSCFWVAVLD GNVVGIVAAR AHEEDNTVEL LRMSVDSRFR GKGIAKALGR KVLEFAVVHN
   241  YSAVVLGTTA VKVAAHKLYE SLGFRHMGAS DHYVLPGMTL SLAERLFFQV RYHRYRLQLR
   301  EE

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against NAT8L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.39
Highest tissue expression
93 nTPM

Expression across tissuesHPA

Tissue

  • cerebral cortex: 93 nTPM
  • basal ganglia: 77 nTPM
  • amygdala: 66 nTPM
  • hippocampal formation: 58 nTPM
  • cerebellum: 46 nTPM
  • midbrain: 43 nTPM

Single-cell type

  • astrocytes: 173 nCPM
  • pituicytes/fscs: 96 nCPM
  • ependymal cells: 67 nCPM
  • retinal horizontal cells: 50 nCPM
  • bergmann glia: 47 nCPM
  • oligodendrocyte progenitor cells: 40 nCPM

Immune cell

  • plasmacytoid DC: 0.9 nTPM
  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM
  • intermediate monocyte: 0 nTPM

Brain region

  • cerebral cortex: 265 nTPM
  • thalamus: 251 nTPM
  • pons: 186 nTPM
  • amygdala: 179 nTPM
  • medulla oblongata: 172 nTPM
  • midbrain: 161 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about NAT8L.

Disease | AllUniProt

Conditions NAT8L is implicated in, by any mechanism.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.46
gnomAD pLI
0.86
gnomAD missense Z
2.15
DepMap mean gene effect
-0.04
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

  • L-aspartate N-acetyltransferase activity

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads NAT8L as an antibody target. Whether an autoantibody or antibody against NAT8L could matter depends on whether native NAT8L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

NAT8L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label NAT8L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/NAT8L. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...